Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST

SHA:600351 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,8994,4914,3855,2154,5286,992
Market Cap Growth
11.10%2.42%-15.93%15.19%-35.24%82.33%
Enterprise Value
4,0113,8993,9524,9114,5207,195
Last Close Price
7.086.305.636.235.278.04
PE Ratio
15.4314.0318.0726.1343.2637.37
Forward PE
-15.8915.8915.8915.8915.89
PS Ratio
2.232.011.631.791.672.53
PB Ratio
1.751.591.521.741.512.36
P/TBV Ratio
1.821.651.611.871.622.59
P/FCF Ratio
8.558.5610.0313.1111.3720.42
P/OCF Ratio
7.967.839.3010.489.8315.98
PEG Ratio
-2.552.552.552.552.55
EV/Sales Ratio
1.831.741.471.691.662.60
EV/EBITDA Ratio
8.198.069.5710.9813.3719.77
EV/EBIT Ratio
11.3811.1514.2816.8525.3836.59
EV/FCF Ratio
7.007.439.0412.3511.3521.01
Debt / Equity Ratio
0.010.010.030.070.150.18
Debt / EBITDA Ratio
0.080.070.230.461.291.47
Debt / FCF Ratio
0.060.070.220.531.111.57
Net Debt / Equity Ratio
-0.30-0.28-0.17-0.14-0.070.02
Net Debt / EBITDA Ratio
-1.71-1.62-1.17-0.91-0.670.17
Net Debt / FCF Ratio
-1.45-1.49-1.10-1.03-0.570.18
Asset Turnover
0.640.660.730.730.660.68
Inventory Turnover
3.152.923.102.802.512.15
Quick Ratio
3.053.121.831.601.401.23
Current Ratio
3.924.102.682.231.881.79
Return on Equity (ROE)
10.49%10.49%7.61%6.00%3.50%6.36%
Return on Assets (ROA)
6.43%6.40%4.68%4.56%2.71%3.04%
Return on Invested Capital (ROIC)
14.27%12.58%8.49%8.93%5.11%5.84%
Return on Capital Employed (ROCE)
12.30%12.10%9.30%9.50%5.80%6.40%
Earnings Yield
6.52%7.13%5.54%3.83%2.31%2.68%
FCF Yield
11.70%11.69%9.97%7.63%8.80%4.90%
Dividend Yield
5.78%-5.33%2.41%0.95%1.00%
Payout Ratio
109.47%66.21%46.79%25.69%77.98%32.29%
Buyback Yield / Dilution
2.72%3.29%5.25%0.89%-0.02%0.04%
Total Shareholder Return
8.51%3.29%10.58%3.30%0.93%1.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.